• Vivesto reports positive Cantrixil results in an animal hematological cancer model

    April 1, 2025

    Read more

  • Notice of Annual General Meeting in Vivesto AB

    April 8, 2025

    Read more

  • Report from Annual General Meeting in Vivesto AB

    May 8, 2025

    Read more

  • Annual report 2024

    April 8, 2025
    (Only distributed in Swedish)

    Read the report

Vivesto licenses Apealea to China’s Zhida Pharmaceutical

March 18, 2025

Read more

CEO corner

Learn more (in Swedish)

Press releases

All press releases

Interim Report Q1 2025 (in Swedish)

Vivesto published its Q1 report for 2025 on May 8, 2025, at 08.00 am CEST.

Read the report (in Swedish)

Calendar

All events

The Share

Follow the share
Visit our Investor section

Annual Report 2024

Read the report